Dr. Denise A. Yardley

Dr. Denise A. Yardley, MONALEESA-2 Investigator, Breast Cancer Research Program, Sarah Cannon Research Institute and Shirley A. Mertz, President, Metastatic Breast Cancer Network: Advancements in Metastatic Breast Cancer Treatments

by with No Comment EducationHealthRadio and Podcast

According to The American Cancer Society, Metastatic breast cancer (mBC) is the most serious form of the disease and takes a life in the United States approximately every 12 minutes creating an urgent need for treatment proven to extend life while preserving quality of life. My guests, Dr. Denise A. Yardley, a MONALEESA-2 Investigator, Breast Cancer Research Program, Sarah Cannon Research Institute and Shirley A. Mertz, President, Metastatic Breast Cancer Network, join me with the updated results of a targeted treatment from the Monaleesa-2 trial.

Yardley_Denise – TALK! with AUDREY RADIO

Positive News Continues To Emerge For Advanced Breast Cancer Patients – TALK! with AUDREY RADIO

by with No Comment HealthRadio and Podcast

Up to 11% of new breast cancer cases are initially stage IV or metastatic. While there have been many advances in treatment, metastatic breast cancer remains incurable. Despite treatment advancements, metastatic breast cancer continues to take the lives of approximately 113 people in the US every day. Dr. Denise Yardley Senior Investigator, Breast Cancer Research Program, Sarah Cannon Research Institute at Tennessee Oncology has some positive news for advanced breast cancer patients.